January 1, 2022, the second screening round of the reorganized Dutch cervical cancer population programme, using primary HPV humaan papillomavirus (humaan papillomavirus) screening, has started. From this date, people with a known HPV result from the previous round will be invited for screening. The effects of these changes were evaluated, by evaluating the size of the screening programme and screening behaviour, and the results of screening.